Draft BARDA Strategic Plan for Medical Countermeasure Research, Development, and Procurement

On December 19, 2006, President George W. Bush signed into law the Pandemic and All-Hazards Preparedness Act (Public Law 109-417), referred to as PAHPA.   Title IV of PAHPA established the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services (HHS) to facilitate the research, development, and acquisition of medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) agents and emerging infectious diseases, including pandemic influenza, that threaten the U.S. civilian population.  BARDA establishes systems that encourage and facilitate the development and acquisition of medical countermeasures such as vaccines, therapeutics and diagnostics, as well as innovative approaches to meet the threat of CBRN agents and emerging infectious diseases, including pandemic influenza, in support of the mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (HHS PHEMCE).

BARDA, in concert with its partners throughout HHS, has created the Draft Biomedical Advanced Research and Development Authority Strategic Plan for Medical Countermeasure Research, Development, and Procurement (Draft BARDA Strategic Plan) as a comprehensive approach for how BARDA will guide and facilitate the research, development, innovation, and procurement of medical countermeasures in fulfillment of Section 401(b) of PAHPA.

The  Draft BARDA Strategic Plan is built upon the framework established in national strategies for CBRN and pandemic influenza medical countermeasures, specifically the National Strategy for Pandemic Influenza and the National Strategy for Medical Countermeasures against Weapons of Mass Destruction (Homeland Security Presidential Directive-18).

Full Text: Draft BARDA Strategic Plan for Medical Countermeasure Research, Development, and Procurement (PDF - 151.9 KB)*

*Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.